James L L Tullis
CIK 1230641 · last filed 2026-09-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ATEC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
STAMFORD, CT 06907
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CR | Director | 5,435 | $192.27 | $1.04M | -$220.3K | 10 | 2026-09-02 |
| CXT | Director | 9,960 | $57.19 | $569.6K | $0 | 9 | 2026-05-26 |
| ATEC | Director | 797,893 | $10.71 | $8.55M | -$7.83M | 20 | 2023-09-13 |
| XGN | Director | 25,885 | $7.78 | $201.4K | -$1.80M | 20 | 2022-06-21 |
| ECOR | Director | 129,277 | $7.82 | $1.01M | $1.59M | 5 | 2020-04-16 |
| INTERPHARM HOLDINGS INC (IPA) Delisted | 10%+ Owner | — | $2.07 | — | $0 | 1 | 2008-02-29 |
| VIACELL INC (VIAC) Delisted | Director | 1,753,221 | $29.58 | $51.86M | -$375.0K | 2 | 2007-01-29 |
Recent Filings · Page 11 of 11
108 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-05-16 | — | Buy (P) | +3,000 | $123.1K | |
| 2008-05-13 | — | Buy (P) | +1,000 | $40.4K | |
| 2008-04-23 | — | Grant (A) | — | $0 | |
| 2008-03-03 | — | Other (J) | +500 | $21.4K | |
| 2008-02-29 | INTERPHARM HOLDINGS INC (IPA) Delisted | Other (J) | — | $0 | EDGAR |
| 2007-04-25 | — | Grant (A) | — | $0 | |
| 2007-01-29 | VIACELL INC (VIAC) Delisted | Mixed | +187,437 | -$3 | EDGAR |
| 2007-01-22 | VIACELL INC (VIAC) Delisted | Other (J) | −500,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.